Cite
HARVARD Citation
Lin, D. et al. (2021). Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe. Journal of clinical hypertension. 23 (3), pp. 556-567. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lin, D. et al. (2021). Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe. Journal of clinical hypertension. 23 (3), pp. 556-567. [Online].